Our mission is to deliver research leading to better cancer prevention, diagnosis and treatment, by recruiting outstanding talent and providing world-class training programs to nurture the next generation of research innovators.
Devoted to the Cause
We are committed to the fight against cancer. Our priority is to harness basic science discoveries to create more effective, as well as improve existing cancer treatments.
Research with a Focus
Our areas of focus lie particularly in Aerodigestive Tracts Cancers, Breast and Female Cancers and Hematologic Malignancies, which are prevalent in Asian populations, along with a breast cancer working group examining Asian phenotypes.
We pursue excellence relentlessly and continually seek to innovate and revolutionize cancer research. In support of research excellence, CSI houses a full spectrum of basic and clinical translational facilities with a multitude of state-of-the-art core support technologies. These sophisticated technologies provide robust investigational resources for CSI and also the wider NUS community.
We are an advocate of collaborative partnerships both within the Institute and with other institutes. CSI works closely with basic scientists and clinicians across Singapore in various institutes, including the National University of Singapore (NUS), National University Hospital (NUH), National Cancer Institute Singapore (NCIS), Duke-NUS Graduate Medical School and Institute of Molecular and Cell Biology (IMCB). To accomplish our research goals, we initiated and lead the Frontiers in Cancer Science, an annual cancer conference offering researchers globally a major platform to engage in world-class scientific partnerships.
We are dedicated to inspire and mentor the young researchers of today to produce an outstanding generation of scientists for tomorrow.